|
| |
| |
|
 |
Promega enters into
agreement with GeneCopoeia To deliver cloned gene content ready for multiple
proteomics applications
|
Madison, WI USA. (April 22, 2008) Promega has
entered into an agreement with GeneCopoeia to combine its HaloTag® protein
fusion technology with GeneCopoeia’s extensive library of human and mouse open
reading frame (ORF) OmicsLink™ sequences. The resulting OmicsLink ORF expression
clones with HaloTag are ready for use, offering a potentially weeks of time
savings to customers.
The large number of expression-ready ORF clones with HaloTag, combined with
fluorescent or other ligands for HaloTag and optimized assay protocols, provide
a complete solution broadly applicable to proteomics research, supporting both
biochemical and cellular analysis of protein function.
“Our aim is to support scientists in their research, and this combined resource
will enable them to easily incorporate these tools to improve protein function
experiments,” explains Promega VP of Marketing Andy Bertera. “This collaboration
with GeneCopoeia allows us to offer incredible breadth of prepared gene content
to complement the multiple protein applications enabled by the HaloTag
platform.”
“HaloTag complements our collections of genome-wide OmicsLink full length cDNA
clones from human, mouse and other species," said Dr. Sun Lu, Executive Vice
President of GeneCopoeia, Inc. GeneCopoeia’s 20,000 human and 15,000 mouse ORF
clones were generated from sequence validated full length cDNA clones or high
quality tissue cDNA libraries using the Company’s proprietary high-fidelity
cloning technologies.
HaloTag is a multi-functional protein tag that binds covalently and specifically
to a variety of synthetic ligands, and which enables tagged proteins to be
labeled with fluorophores for both in vitro and in vivo imaging, or with
immobilization agents (beads or other surfaces) for purification. Covalent and
specific binding of a variety of synthetic reporter and immobilization ligands
to HaloTag fusion proteins allow detection and or solid-phase fixation of tagged
proteins.
For further information please visit
www.genecopoeia.com/product/halo
- ENDS -
About Promega
Promega Corporation is a leader in providing innovative solutions and technical
support to the life sciences industry. The company’s 2,000 products enable
scientists worldwide to advance their knowledge in genomics, proteomics,
cellular analysis, molecular diagnostics and human identification. Founded in
1978, the company is headquartered in Madison, WI, USA with branches in 14
countries and over 50 global distributors. For more information about Promega,
visit
www.promega.com .
About GeneCopoeia
GeneCopoeia, Inc. is a US-based manufacturer and provider of genomics and
proteomics products and services for academic and governmental research
institutes, pharmaceutical and biotechnology industry. The company is
headquartered in the I-270 Hi-Tech corridor in the state of Maryland. Together
with investors in China, GeneCopoeia formed a joint venture, FulenGen Co., Ltd.
in P.R. China, which has been in operation since year 2000. GeneCopoeia and its
joint venture, FulenGen have manufactured and released into market the largest
number of human full length protein coding ORF cDNA clones in multiple sets of
vector systems with various features which make these clones suitable for a
variety of functional assays, protein expression and easy purification in many
cell types as well as cell free transcription and translation coupling systems,
and large scale functional genomics and proteomics studies Further information
at:
www.genecopoeia.com .
# # # #
Contact
Promega
Penny Patterson
Director, Corporate Affairs
T: +1 (608) 274-4330
E:
penny.patterson@promega.com
College Hill
Lorna Cuddon, Katie Odgaard, Rebecca Walker
T: +44 (0)20 7457 2020
E:
promega@collegehill.com
| |
|
